Evidence map›Paper›PMID 41899412›Full record

ArticleCurrent issues in molecular biology2026

Synthesis and Antimicrobial Activity of Novel Fluoroquinolone with Geranyl Amine Moiety.

Ilmir R Gilfanov, Svetlana A Lisovskaya, Daria P Gerasimova, Evgeniy S Izmest'ev, Olga B Babaeva, Denis V Sudarikov, Pavel V Gribkov, Iva I Zadorina, Airat R Kayumov, Liliya E Nikitina

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ilmir R GilfanovInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.ORCID 0000-0003-4351-3378
Svetlana A LisovskayaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.ORCID 0000-0002-4377-2567
Daria P GerasimovaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of the Russian Academy of Sciences, 420088 Kazan, Russia.ORCID 0000-0001-9770-196X
Evgeniy S Izmest'evInstitute of Chemistry, Federal Research Center "Komi Scientific Centre", Ural Branch, Russian Academy of Sciences, 167000 Syktyvkar, Russia.ORCID 0000-0001-5698-6292
Olga B BabaevaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of the Russian Academy of Sciences, 420088 Kazan, Russia.
Denis V SudarikovInstitute of Chemistry, Federal Research Center "Komi Scientific Centre", Ural Branch, Russian Academy of Sciences, 167000 Syktyvkar, Russia.ORCID 0000-0001-5640-6956
Pavel V GribkovInstitute of Chemistry, Federal Research Center "Komi Scientific Centre", Ural Branch, Russian Academy of Sciences, 167000 Syktyvkar, Russia.
Iva I ZadorinaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
Airat R KayumovInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.ORCID 0000-0001-7195-1557
Liliya E NikitinaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.ORCID 0000-0003-2113-5732

Funding

Kazan Federal University FZSM-2025-0003
6 · The paper itself

Abstract

The rapid emergence and global spread of antimicrobial resistance necessitate the development of novel antibacterial molecules. A promising strategy is the fusion of conventional drugs with fragments of natural compounds possessing various biological activity. In this study, we report the synthesis and antimicrobial activity of a novel fluoroquinolone carrying acyclic monoterpene moiety derived from geranyl amine. Compound

Indexed as

antimicrobial activityfluoroquinolonegeranyl aminemonoterpenoid

Identifiers

PMID41899412
PMCPMC13024941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.